Vivos Therapeutics Inc
NASDAQ:VVOS

Watchlist Manager
Vivos Therapeutics Inc Logo
Vivos Therapeutics Inc
NASDAQ:VVOS
Watchlist
Price: 2.63 USD -2.59% Market Closed
Market Cap: 12.5m USD
Have any thoughts about
Vivos Therapeutics Inc?
Write Note

Gross Margin
Vivos Therapeutics Inc

60.1%
Current
66%
Average
47.3%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
60.1%
=
Gross Profit
8.4m
/
Revenue
14m

Gross Margin Across Competitors

Country US
Market Cap 12.5m USD
Gross Margin
60%
Country US
Market Cap 89.4B USD
Gross Margin
12%
Country US
Market Cap 80.2B EUR
Gross Margin
12%
Country US
Market Cap 70.9B USD
Gross Margin
15%
Country DE
Market Cap 21B EUR
Gross Margin
25%
Country DE
Market Cap 18.7B EUR
Gross Margin
23%
Country US
Market Cap 19.1B USD
Gross Margin
28%
Country US
Market Cap 17.4B USD
Gross Margin
33%
Country MY
Market Cap 58.5B MYR
Gross Margin
-120%
Country US
Market Cap 11.9B USD
Gross Margin
33%
Country DE
Market Cap 10.5B EUR
Gross Margin
25%

Profitability Report

View the profitability report to see the full profitability analysis for Vivos Therapeutics Inc.

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
60.1%
=
Gross Profit
8.4m
/
Revenue
14m
What is the Gross Margin of Vivos Therapeutics Inc?

Based on Vivos Therapeutics Inc's most recent financial statements, the company has Gross Margin of 60.1%.